
|Articles|May 4, 2008
Immune drug effective for scalp psoriasis
New York - Alefacept, a drug that reduces the activity of certain immune cells, effectively treats scalp psoriasis, Reuters Health reports.
Advertisement
New York
- Alefacept, a drug that reduces certain immune cell activity, effectively treats scalp psoriasis, Reuters Health reports.
The study, published in the Journal of the American Academy of Dermatology, evaluated the safety and efficacy of alefacept in treating scalp psoriasis in 30 adults, who received weekly injections for 16 weeks, and then no treatment for 12 weeks.
After one or two courses, 16 patients had at least a 75 percent improvement, researchers report.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
2
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
3
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
4
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
5











